trial → CapableOf → fail to show benefit
Typicality: 0.397
Saliency: 0.247
Facets 3
for the heart 6 transitive-object
from adding imatinib 2 other
over placebo 2 other
Open triples 2
trial → fail to show → benefit 11
trial → fail to show → any benefit 3
Sentiment analysis
negative neutral positive
0.614 0.343 0.044
Other statistics
Raw frequency 14
Normalized frequency 0.247
Modifier score 0.900
Perplexity 112.458